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Abstract 
Background: Chlamydia trachomatis (CT) is the most common reportable sexually transmitted 
infection (STI) in the United States. Despite regulatory agencies’ recommendations, routine CT 
screening is not being performed in many high-risk settings. Problem: The burden of undetected 
CT infections is substantial to patients and the healthcare system. There is a lack of consensus 
regarding an effective standardized CT screening strategy and screening rates remain suboptimal. 
Methods: A standardized CT screening, testing, and treatment process was implemented in 
Spring of 2020 and compared to screening rates pre-intervention in Spring 2019. Intervention: A 
3-question sexual health screening questionnaire (SHSQ) was administered to all patients aged 
18 - 24 years seeking care at the Millersville University Health Center (MUHS). Results: There 
were 1613 visits from Spring 2019 (n=675) and Spring 2020 (n=938) semesters. The final 
sample of 473 visits included those screened in Spring 2019 (n=65) and Spring 2020 (n=408). 
The screening rate increased from 9.6% in Spring 2019 to 43.5% in Spring 2020. There was a 
statistically significant difference in the pre- and post-groups who received a CT test (100% 
vs.18.4%, respectively, p = .00). Among the 140 students tested for CT, there was no statistically 
significant difference in detection of CT between the 2019 and the 2020 group and all students 
who tested positive were treated. Conclusion: This project resulted in an increase of 34 
percentage points in CT screening at MUHS. The findings of this project reinforce regulatory 
agencies’ concerns that CT screening rates remain suboptimal as only 34.3% of participants 
indicated they were tested for CT within the past year (n=140). 
 
Keywords: Chlamydia screening, chlamydia testing, STI screening, STD screening, college, and 
primary care  
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Title of Project 
Implementing Standardized Chlamydia Screening in a College Health Center. 
Background 
Chlamydia trachomatis (CT) is the most common reportable sexually transmitted 
infection (STI) in the United States with the highest prevalence rates in adolescents and young 
adult women, causing significant morbidity when left undetected (Centers for Disease Control 
and Prevention [CDC], 2019). Despite recommendations from the CDC (2015), the U.S. 
Preventative Services Task Force (USPSTF, 2016), and the National Committee for Quality 
Assurance (NCQA, 2018) for routine annual CT screening of sexually active women younger 
than 25 years of age, many high-risk populations are still not being screened. Screening is 
important for CT detection, as approximately 75% of CT infections in women and 95% of 
infections in men are asymptomatic (NCQA, 2018).  
Problem Statement 
The burden of undetected CT infections is substantial to patients and the healthcare 
system in the United States. Untreated CT infection can result in pelvic inflammatory disease 
(PID), which is a major cause of infertility, ectopic pregnancy, and chronic pelvic pain (CDC, 
2019).  Additionally, the USPSTF (2016) estimated that the lifetime direct medical costs for CT 
were $516.7 million (in 2010 dollars).  
Although many regulatory agencies have emphasized the importance of screening 
sexually active high-risk populations, there is a lack of consensus regarding an effective 
standardized screening strategy and screening rates remain suboptimal. The purpose of this 
project was to implement a standardized CT screening, testing, and treatment process for 
students at a college health center to increase the detection and treatment rate of CT infections on 
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a college campus. The population, intervention, comparison, and outcome (PICO) question for 
the Doctor of Nursing Practice (DNP) project was: In students 18 - 24 years of age seeking 
clinical services in a college health center (P), does implementation of standardized CT screening 
(I), as compared to complaint-based CT screening (C), increase the detection and treatment of 
CT (O)? 
Needs Assessment 
Many individuals who are at risk are still not being tested for CT, reflecting the lack of 
awareness among some providers and the limited resources available to support these screenings 
(CDC, 2019). A fishbone diagram (see Appendix A) was used to investigate the possible causes 
of low CT screening rates. Common barriers to screening cited by patients include: (a) insurance 
(or lack thereof), (b) confidentiality, (c) cost, (d) embarrassment, (e) stigma, and (f) perceived 
lack of risk (Griner et al., 2019; Myers, McCaskill, & VanRavenstein, 2017; Reed et al., 2017; 
Schneider, FitzGerald, Byczkowski, & Reed, 2016). Providers cited screening barriers such as 
(a) lack of financial support or reimbursement, (b) comfort level discussing sexual health, (c) 
time constraints gathering specimens, (d) lack of knowledge regarding public health 
implications, and (e) lack of training (Myers et al., 2017).  
Pre-implementation CT screening at Millersville University Health Services (MUHS) 
was complaint-based, meaning testing was only completed on symptomatic patients or at the 
patient’s request. A strength, weaknesses, opportunities, and threats (SWOT) analysis (see 
Appendix B) was used to evaluate the internal and external attributes of the project environment 
at MUHS. Strengths included confidential CT testing and treatment for a relatively low cost. A 
primary obstacle was the increased time and effort required by nurses and healthcare providers, 
which could cause some resistance to implementation. Implementation of CT screening in this 
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high-risk population provided the opportunity to increase CT detection and treatment rates, 
decrease morbidity rates, and thus improve the overall health on the Millersville University 
campus. External threats to implementation include other sites that offer free testing or accept 
insurance.  
Aims, Objectives, Purpose Statement 
This project aimed to determine if implementation of standardized CT screening among 
students aged 18 - 24 years in a college health center increased the testing, detection, and 
treatment of CT. The primary objective over the 4-month period was to screen at least 90% of 
students (aged 18 - 24 years) for CT who presented for a provider visit, using a sexual history 
screening questionnaire (SHSQ). All patients who screened positive (sexually active and have 
not been tested for CT in the past 12 months) on the SHSQ during the 4-month screening period 
were offered CT testing. Another objective was to achieve at least a 10% increase in the 
proportion of students (aged 18 - 24 years) tested for CT infection over a 4-month period. The 
purpose of this project was to implement a standardized CT screening, testing, and treatment 
process for students at a college health center to increase the detection and treatment rate of CT 
infections on a college campus.  
Review of Literature 
A literature review was conducted from August 2018 to January 2020 using the 
keywords: chlamydia screening, chlamydia testing, STI screening, STD screening, college, and 
primary care. The databases used were CINAHL and PubMed. Limits were set to only include 
articles written in the English language and date limits were set to the most recent 5 years. 
Twenty articles were found, and nine articles met inclusion criteria (see PRISMA diagram in 
Appendix C). Articles were critiqued using the Johns Hopkins Nursing Evidence-Based Practice 
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Research Evidence Appraisal Instrument (see evidence matrix in Appendix D; Dang & Dearholt, 
2018). 
Researchers found statistically significant increases in CT screening in high-risk settings 
when standardized CT screening was implemented (DiVasta et al., 2016; Karas, Sondike, 
Fitzgibbon, Redding, & Brown, 2018; Myers et al., 2017; Owusu-Edusei, Hoover, & Gift, 2016; 
Wood et al., 2019). Additionally, Myers et al. (2017) found an increase in testing and a decrease 
in the CT infection rate after implementation of a routine CT screening protocol. Similarly, 
Karas et al. (2018) found 11% of the asymptomatic females for whom alerts were fired were 
positive for CT and Schneider et al. (2016) found 9.9% of participants were positive for CT. 
Griner et al. (2019) found that many participants described that the testing should be low cost to 
students. Furthermore, participants noted self-sampling methods to be straightforward, preferable 
to collect or drop off on campus without interaction with a provider, and affordable at $20-$30 
(Griner et al., 2019). 
Theoretical Model 
The theory used to guide this project was Betty Neuman’s systems model (Appendix E). 
Neuman’s systems model focuses on the response of the patient system to environmental 
stressors and the use of primary, secondary, and tertiary nursing prevention (Utley, Henry, & 
Smith, 2018). Neuman’s system model guided the project to promote health, using all three 
categories of prevention, with the goal of decreasing morbidity due to undetected CT infections. 
Translation Model 
The Johns Hopkins Nursing Evidence-Based Practice model (see Appendix F) was used 
to translate the evidence into practice (Dang & Dearholt, 2018). Evaluation of outcomes included 
gathering data pre- and post-intervention to determine CT screening, detection, and treatment 
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rates. Adjustments were made throughout the project using the practice question, evidence, 
translation (PET) process for evidence-based practice, as this involved a continuous loop of 
learning and practice improvement (Dang & Dearholt, 2018). The results were shared with key 
stakeholders throughout the project. 
Methodology 
This quality improvement (QI) project aimed to increase the number of students at 
MUHS screened for CT through the implementation of a standardized CT screening, testing, and 
treatment process. The strategy used for CT screening at MUHS followed the age-based 
screening pathway for asymptomatic females, 24 years and younger (see Appendix G), provided 
by the Altarum Institute (2016). A 3-question SHSQ was implemented during the rooming 
process on all individuals who were aged 18 - 24 years. A convenience sample of patients who 
were administered the 3-question SHSQ in the Spring of 2020 was compared to those who were 
tested for CT in the Spring of 2019 when only complaint-based screening methods were used. 
Participants 
Due to the high prevalence in young adults, the CDC recommended screening not just 
young women, but all individuals aged < 25 years for STIs (Myers et al., 2017). Additionally, the 
CDC (2015) recommended screening sexually active young men who have sex with men (MSM) 
or men in clinical settings serving a population with a high prevalence of CT, such as college 
health centers. Therefore, participants included all students aged 18 - 24 years presenting for an 
office visit at MUHS. Exclusion criteria included students who were (a) 25 years of age or older, 
(b) less than 18 years of age, or (b) not sexually active.  
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Setting 
Millersville University (2019) is a rural public university located in Lancaster, 
Pennsylvania, with an estimated 7,000 undergraduate students. Free health services are provided 
to all students who attend the university and are funded in part by student fees paid each 
semester. MUHS offers confidential CT/gonorrhea (GC) testing and treatment for $15, which the 
patient can choose to self-pay or have billed as a generic MUHS charge on their student account. 
MUHS includes (a) six exam rooms; (b) four offices for providers, nursing staff, and the office 
manager; (c) a laboratory for processing specimens; and (d) a dispensary for medications. The 
full-time nurse practitioner is the main provider and, occasionally, there is additional provider 
coverage by a physician. During the school year, additional staff consist of three registered 
nurses (RNs), an administrative assistant, and the nurse manager.  
Tools 
Given the lack of a standardized CT screening tool in existence, a 3-question SHSQ (see 
Appendix H) was developed following CT screening guidelines from the CDC (2015), USPSTF 
(2016), and NCQA (2018). The SHSQ was administered to all patients aged 18 - 24 years 
seeking care at MUHS due to the high-risk population and setting.  The SHSQ provided a 
standardized tool for the implementation of the CDC (2015) recommendation for annual CT 
screening for all sexually active women aged < 25 years and men in high-prevalence settings.  
Similarly, the USPSTF (2016) recommended annual CT screening in sexually active MSM or 
males in high prevalence rates. Additionally, the SHSQ is consistent with the Healthcare 
Effectiveness Data and Information Set (HEDIS) measure analyzing “the percentage of women 
16-24 years of age who were identified as sexually active and who had at least one test for CT 
during the measurement year” (NCQA, 2018, para. 1).  
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Intervention 
An electronic medical record (EMR)-based prompt alerted the RN to administer the 
SHSQ upon rooming the patient. If the patient met inclusion criteria and had a positive SHSQ 
(sexually active, no CT test within the past year, and/or symptomatic), the nurse offered CT/GC 
testing to the patient and provided the patient with an STI handout that the patient reviewed 
while waiting for the provider (see Appendix I). The provider (a) reviewed the patient’s sexual 
history; (b) discussed any areas of concern, testing, and treatment options; and (c) provided 
information on sexual health. A process map of the intervention is included in Appendix J. 
Comparison (Pre-Intervention) 
Complaint-based screening was the only screening method being used prior to the project 
intervention. Therefore, only students who requested CT testing or who presented with 
symptoms that could be attributed to a STI were offered or tested for CT in Spring 2019. It is 
known that most cases of CT are asymptomatic and symptoms, when present, are vague 
(Altarum Institute, 2016).  Therefore, without assessing for symptoms or risk factors, especially 
in high risk populations, such as a college health center, many CT infections may go undetected 
and continue to spread among the population. 
Data Collection 
The project was implemented during the Spring 2020 semester (1/21/2020 – 3/12/2020). 
Demographic data (gender, ethnicity, and age) were collected in the EMR to evaluated for 
differences. Outcomes were measured by gathering data from the EMR, including the number of 
students screened, tested, and treated for CT. Data collected during the implementation period 
was compared to pre-intervention data from the Spring 2019 semester (1/21/2019 – 3/12/2019) 
to evaluate the relationship of the intervention to CT screening, testing, and treatment rates.  
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Cost Analysis 
There were a few direct costs considered in the implementation of this project (see 
Appendix K). The highest direct cost was a $175 fee to call Point and Click, the company that 
manages the EMR system, to add the SHSQ prompt into the EMR. The use of MUHS printer and 
ink, which were already in place, to make handouts was estimated at $20 for MUHS over the 
duration of the project. Otherwise, this DNP project was created to be without financial cost 
utilizing available MUHS resources. The total cost of this project to MUHS was $195. 
Timeline 
The timeline for the actualization of this project is illustrated through a Gantt chart 
attached in Appendix L. Proposal approval was obtained in May 2019. A meeting was held with 
the staff at MUHS in October 2019 and an in-service was held just before implementation in 
January 2020. Data collection and review occurred throughout the implementation in January 
2020 to March 2020. Although the intention was to implement the project for the entire Spring 
2020 semester, due to the coronavirus pandemic data collection was cut short when students 
were sent home at spring break for the remainder of the semester. Therefore, data was collected 
from January 21, 2020 to March 12, 2020. Data analysis and interpretation of outcomes occurred 
post-intervention from May 2020 to July 2020. The final report of the findings was completed in 
August 2020. 
Ethics and Human Subject Protection 
Messiah University and Millersville University Institutional Review Board (IRB) 
approval was obtained before initiating the DNP Project (see Appendix M). All participants were 
protected by the Health Insurance Portability and Accountability Act of 1996 (HIPAA), which 
protects the privacy and security of the individuals’ health information (Modifications to the 
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HIPAA Privacy, Security, Enforcement, and Breach Notification Rules, 2013). Informed consent 
was obtained through implicit consent for medical treatment. The Millersville University and 
Messiah University IRBs waived written informed consent. It is important to note that 
participants could decline to answer any questions, therefore withdrawing or discontinuing their 
participation in the project at any point in time.  
There were no risks in participating in this research beyond those experienced in 
everyday life. The identity of the participants was protected using a password-protected EMR 
system to obtain and store answers to the SHSQ. Similarly, deidentified data were stored in a 
password-protected computer and file, accessed only by the researchers involved in the project. 
This project used aggregate data; therefore, personal identifiers were not linked to the data used 
in the project.  
Results: Data Analysis and Evaluation 
Data were maintained and analyzed with IBM SPSS Statistics for Windows, Version 26.0 
(IBM Corp, 2019). To evaluate differences between the 2020 intervention group and the 2019 
comparison group for demographics (gender and ethnicity), a Pearson’s chi-square test or 
Fisher’s exact test was used as appropriate; differences in age between the two groups were 
evaluated using an independent samples t-test. The outcome variables (tested, result, and 
treatment) were examined to assess assumptions for nonparametric testing. Statistical 
significance was established as p < .05. 
Sample Characteristics 
There were 1613 visits from Spring 2019 (n=675) and Spring 2020 (n=938) semesters. 
Of these, 473 patient visits (408 in 2020 intervention group, 65 in 2019 comparison group), met 
inclusion criteria and were included in the final sample (see appendix N). The final sample had a 
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mean age of 20.29 years of age (SD 1.53), the majority of subjects were female (73.6%, n = 
348), and were White (68.1%, n = 322). There were no statistically significant differences in the 
original potential sample or the final sample for age [t (1611) = -.82, p = .41], gender [x2(1) = 
2.46, p = .12], or ethnicity [x2(3) = 3.79, p = .28].  
Additionally, there were no statistically significant differences between the intervention 
group and the comparison group for age [t (471) = 1.52, p = .84]. However, there were 
statistically significant differences in the intervention group and the comparison group for gender 
[x2(1) = 7.14, p = .008] and ethnicity [x2(3) = 17.09, p = .001].  While it is important to recognize 
that these are potential confounders, considering the lack of true CT screening in the 2019 
comparison group and the amount of missing data, a correction calculation was not felt to be 
necessary, nor would it have affected the findings. 
Findings 
Implementation of a standardized CT screening protocol at MUHS resulted in an increase 
in screening rates of individuals age 18-24 years of age. The screening rate increased from 
65/675 (9.6%) in Spring 2019 to 408/938 (43.5%) in Spring 2020. Thus, a 34 percentage point 
increase in CT screening from the pre-to post-intervention group was noted.  
Of the 408 participants in the 2020 (3-question SHSQ) group, 92.6% (n = 378) stated 
they were sexually active (see Appendix O). However, only 34.3% stated they were tested for 
CT within the past year (n = 140). As such, 58.4% (n = 237) had a positive screen, meaning they 
were sexually active but did not have a CT test in the past year and/or they had symptoms. All 
patients who had a positive screen were offered CT testing, therefore meeting one of the primary 
objectives of this QI project. 
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There was a statistically significant difference in the proportion of students who received 
a CT test between groups (see Appendix P), with 100% (n = 65) of the students in the 2019 
(complaint-based screening) group being tested compared to 18.4% (n = 75) of students in the 
2020 (3-question SHSQ) group [x2 (1) = 179.23, p = .00]. Note that only the students tested in 
2019 were included in the complaint-based screening group, however, all students given the 3-
question SHSQ were included in the intervention group. Additionally, it is important to note, that 
significantly more students in the 2019 sample compared to 2020 sample reported symptoms 
(55.4% vs. 33.3%, x2(1) = 6.88, p = .009). This is a potential confounder for detection, results, 
and treatment.  
Among the 140 students who were tested for CT, there was no statistically significant 
difference in detection of CT between the 2019 (complaint-based screening) group vs the 2020 
(3-question SHSQ) group [24.6% vs. 16%, x2(1) = 1.61, p = .200]. As such, the objective to 
achieve at least a 10% increase in the proportion of students tested for CT during the 
implementation period was not met.  Of the 140 CT tests done, 30.7% (n = 43) were positive and 
all of these students were treated. An additional 13.4% (n = 15) of students who tested negative 
were also treated, but these were treated presumptively based on symptoms. 
Discussion 
Strengths 
This QI project provides a guideline for implementing an evidence-based standardized 
CT screening protocol in a college health center. The complaint-based screening method that was 
being used previously at MUHS occurred only when students complained of symptoms. Students 
were not specifically asked if they were having any symptoms or evaluated for risk factors. By 
not asking about symptoms or risk factors, it is likely that many CT infections were going 
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undetected.  Through implementation of a standardized CT screening protocol, a 34 percentage 
point increase in screening was noted.  
Among students who were screened in 2020 with the 3 question SHSQ (n = 75), 33.3% 
(n = 25) reported symptoms of chlamydia, and of these approximately half scored positive on the 
screening questions (48%, n = 12). Among students who did not report symptoms (n = 50), the 
majority had a positive screen (70%, n = 35). Although there was no statistically significant 
difference (x2(1) = 3.45, p = .06), a greater proportion of students who did not report symptoms 
screened positive (74.5%, n = 35) compared to those who screened negative (53.6%, n = 15), 
indicating that the 3-question SHSQ in addition to symptom screening may identify greater risk 
for CT infection.  
Limitations 
There are several limitations of this project. This QI project was conducted in a rural 
college health center. Participants were aged 18-24 years and in a high-risk setting. As such, 
generalizing to other settings and populations is limited.  
Additionally, during the data collection period, a worldwide pandemic of the COVID-19 
virus occurred. Social distancing measures were implemented in the beginning of March.  As 
such, Millersville University conducted the remainder of the Spring 2020 semester after spring 
break online, thus significantly reducing the number of students who utilized MUHS. A major 
implication of the pandemic on this DNP project was the abbreviated data collection timeframe.  
Thus, shortening the implementation period from the intended 4 months to less than 2 months. 
It is also important to note two major confounders in this QI project. The first of which is 
that significantly more students in 2019 compared to 2020 reported symptoms (55.4% vs. 33.3%, 
x2(1) = 6.88, p = .009). This is a potential confounder for detection, results, and treatment. 
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Second, there was a significant about of missing data in the 2020 group (56.5%), meaning the 
students were not asked all or part of the 3-question SHSQ.  As such, the primary objective to 
screen at least 90% of students for CT who presented for a provider visit, using the SHSQ, was 
not met. 
Recommendations 
Given the limitations of this QI project related to a large amount of missing data for 
screening questions in the 2020 group, significantly greater positive symptoms in the 2019 
groups, and the potential for other confounders, a change in practice is not recommended based 
on this data. Considering a future QI project, a priori power analysis for sample size was 
conducted with G*Power with an effect size of 0.6, alpha = .05, and power of .80 indicating a 
total sample size of 22 students would be required. However, with the project limitations, a 
smaller effect size of 0.2 for the calculation is recommended, which results in a sample size of 
197. The recommendation would be to round up to 200 for future project sample size and 
perform an interim analysis at 100 participants to determine if any issues are noted.  
Additionally, a future QI project with better control for confounders by asking all 
students if they have symptoms of CT would provide greater insight into identifying those at risk 
and increase testing to improve detection and treatment. Given the significant amount of missing 
data, relying on the nurses to collect the data at each visit proved to be ineffective. One 
recommendation would be to have the students complete the questionnaire on the secure 
computer system prior to their visit, perhaps upon checking in for their appointment. The 
questionnaire could list specific symptoms and risk factors for STIs that the student could review 
in the time waiting to be evaluated. The nurses could then review the questionnaire responses 
and clarify any missing data. This type of system could also flag the provider of any risk factors. 
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This would allow for a more complete screening process and would be cognizant of the nurses 
and provider’s time.  
Conclusion 
The burden of undetected CT infections is substantial to patients and the healthcare 
system in the United States. Many regulatory agencies have emphasized the importance of 
screening sexually active high-risk populations, yet screening rates remain suboptimal (CDC, 
2019; NCQA, 2018; USPTF, 2016). The findings of this project reinforce regulatory agencies’ 
concerns that CT screening rates remain poor as only 34.3% of participants indicated they were 
tested for CT within the past year (n=140).  
Researchers found that standardized CT screening in high-risk settings increased 
screening rates, detection, and treatment (DiVasta et al., 2016; Karas et al., 2018; Myers et al., 
2017; Owusu-Edusei et al., 2016; Wood et al., 2019). MUHS provided access to a high-risk 
population, where standardized CT screening was implemented with little to no additional 
burden or cost, with the goal of increasing the detection and treatment of CT infection, thus 
decreasing the morbidity rates in the campus community and preventing future sequela due to the 
untreated CT infection. By implementing a standardized CT screening process, a 34 percentage 
point increase in CT screening rate was noted.  
This QI project adds to the body of literature regarding sexual health habits of high-risk 
populations and provides a starting point for implementing standardized CT screening processes. 
Improvements could include electronic integration of standardized screening questions prior to 
the office visit, detailing symptoms and risk factors for CT and other STIs. Further research is 
needed to explore sexual health habits and risk factors in high-risk settings, such as college 
CHLAMYDIA SCREENING IN A COLLEGE HEALTH CENTER  19 
  
health centers, and the effects of standardized CT screening process on detection and treatment 
rates. 
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 Helpful to achieving the objective 
Harmful 






















● Convenient access to care  
● Free office visits & low-cost 
testing 
● Confidential testing as 
insurance is not used 
● Efficient system in place for 
chlamydia testing 
● EHR can be tailored to 
incorporate screening 
questions 
● Positive staff collaboration and 
rapport 
● Knowledgeable and 
experienced nursing staff 
Weaknesses 
● Provider resistance 
● Additional workload for nursing 
staff 
● Low motivation for provider 
compliance 
● Limited staff 
● May increase visit time 
● Limited hours of operation (no 
nights or weekends) 
● Cost (self-pay) 
● Funding limitations 

























● Access to high risk population 
● Improve health outcomes 
● Decrease morbidity 
● Offer self-collected specimens 
● Eligible for federal Title X 
grants 
● Chlamydia screening 
recommendations by the 
USPTF, NCQA, & CDC 
Threats 
● Can use insurance to cover 
costs at other facilities 
● Free testing at Title X Family 
Planning Clinics 
● EMR is not connected to other 
health systems 
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Purpose: To increase 
Chlamydia screening 
in at-risk young 













Results: LC participants 
demonstrated statistically 
significant increases in 
recommended Chlamydia 
screening (LC1:52.8% 
preintervention to 66.7% 
postintervention; LC2: 
57.8% preintervention to 
69.3% postintervention). 
Additionally, increased 
documentation of sexual 
activity status in the 
record (LC1: 61.2% 
preintervention to 91.2% 
postintervention; LC2: 
43.3% preintervention to 
61.2% postintervention). 
(see Limitations): 
(pg. e7 & e10) 
-Transferability: 
Population consisted of 
self-selected pediatric 
primary care offices 
and participants had a 
high level of screening 
at baseline, therefore 
unable to transfer 
findings to other 
settings or populations. 
V A 
2 Griner, Sexually 






purpose of this study 












for chlamydia or 
gonorrhea in the 
past 12 months 
& n=12 women 
nonscreened for 
chlamydia or 
gonorrhea in the 
past 12 months), 
on a large, 
public university 
in the southeast 
via campus e-
The mean age was 19.5 
years, and those who 
were screened was 
significantly older than 
those who were not 
screened. 
Participants felt the SSM 
kit would be easy to use 
and straightforward. 
Participants identified 
their preference for 
picking up and dropping 
off the kit somewhere on 
campus rather than using 




The participants were 
recruited from a 
convenience sample of 
sexually active college 
women willing to 
participate who may 
have been generally 
more comfortable 
discussing STI 
screening than other 
young adults 
III B 








concerned about parent’s 
perceptions and the desire 
to keep their sexual 
behaviors from their 
parents. 
The main benefit of SSM 
identified by participants 
was not interacting with a 
health care provider. 
Participants emphasized 
that the product should be 
low cost to students. 







primary objective of 
this study was to 
identify the impact 
of a CDS tool on the 
screening rates for 
CT among female 
patients ages 13 to 
21 years presenting 
for preventive care.  
A convenience 




network of 27 
pediatric 
primary care 





The odds of an 
adolescent female being 
screened were 2.143 
times higher after the 
intervention. 
 
-11% of the 
asymptomatic females for 
whom alerts fired were 





The researchers did not 
discuss the 
psychometrics of the 
CDS tools, therefore 
unable to assess 
reliability. 
III B 
4 Myers, Journal of 









routine screening for 
gonorrhea and 
chlamydia among 
young adults 25 
years of age and 










on a private 
residential 
university 
campus in the 
southeastern 
US. 
Results: The screening 
percentage increased 
from 2 to 65.85%. The 
testing percentage 
increased during the post-
intervention phase to 
17.86%. The chlamydia 
infection rate decreased 
from 9.38% pre-
intervention to 6.15% 
post-intervention.  
(see Limitations): (p. 
1253) 
- Transferability: Due 
to the nature of the 
study, using a sample 
of students from one 
university, there is 
limited generalizability 
to a larger population. 
-Auditability: The pre-
and post-intervention 
phases were held at 
different timeframes 
V B 
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5 Oswalt, Journal of 




analysis of the 
American College 
Health Association 




Purpose: To examine 
college student 
health centers 
practices related to 
sexually transmitted 
disease screening 








the ACHA Pap 
and STI survey 
between 2010 
and 2014. 
Results: About 90%of the 
SHCs routinely screened 
sexually active women 
under 26 for CT 
infection. There was a 
significant increase in the 
number of SHCs that 
included pharyngeal and 
rectal screenings for 
MSM. The use of 
cervical swabs dropped 
from over half to less 
than one-third during the 
5 years. For males, a 7% 
decrease in the use of 
urethral swabs and 8% 
increase in the use of 




reported data and self-
selected respondents. 
-Attrition bias: The 
data was deidentified 
which did not allow for 
tracking changes in the 
same schools across all 
5 years. 
III B 
6 Owusu-Edusei Jr., 
American Journal of 




determine the cost 
and effectiveness of 
the proposed Opt-
Out Testing strategy 
when compared with 
the existing Risk-
Based Screening 
approach for young 
women aged 15-24 
years from a societal 
perspective. 
Convenience 




their record is 
flagged at 
check-in as 
having had a 
negative test 
within the past 
12 months, or 
they decline to 
be tested. 
Results: Total chlamydia 
prevalence without any 
screening was 5.2%, 
reducing to 2.7% when 
the Risk-Based Screening 
strategy was introduced. 
When the Risk-Based 
Strategy was replaced 
with the Opt-Out Testing 
Strategy, the total 
prevalence decreased 





transmission model is 
an oversimplification 
of real-world events. 
-Transferability: The 
model was driven by 
female parameters and 
there was a lack of data 




Considering this was a 
V B 
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computer-generated 
model, it is unclear if 
this could be translated 
to other settings in real 
life. 







Purpose: To explore 
adolescent and 
parent or guardian 
attitudes about 




to all adolescents in 
the pediatric ED, as 




using a tablet to 
collect confidential 
information about 






n=40 parents), 2 
pediatric EDs, 
one was an 
urban, tertiary 
care ED and the 
second was a 
satellite 
pediatric ED, 
located in a 
northern suburb. 
Almost all adolescents 
and parents or guardians 
supported offering ED 
gonorrhea and chlamydia 
screening to all teens in 
the pediatric ED.  
Both adolescents and 
parents or guardians cited 
that the benefits of 
gonorrhea and chlamydia 
screening included earlier 
diagnosis and treatment, 
convenience of testing in 
the pediatric ED, and 
prevention of 
transmission of infection. 
Both adolescents and 
parents or guardians 
identified the ability to 
maintain confidentiality 
and patient cost of 
gonorrhea and chlamydia 





often present to the ED 
without their parent, 
making it difficult to 
obtain parental 




requirement may have 
biased the sample 
because adolescents 
who do not require 
parental permission 
may be more willing to 
participate than those 
of whom parental 
permission is required. 
- Transferability This 
study is limited in that 
participants included 
only adolescents and 
parents or guardians 
who visited an urban 
or suburban pediatric 
ED, and it was unclear 
whether these patients 
resided in the 
surrounding urban 
community or were 
from other settings, 
including rural areas. 
III B 
CHLAMYDIA SCREENING IN A COLLEGE HEALTH CENTER  30 
  













adolescents in an 








14-21 years of 
age, who 
presented to the 
PED of a 
children’s 
hospital with a 
non-STI-related 
chief complaint. 
Results: 68% of those 
approached participated 
in the study. Those who 
agreed to STI screening 
were more likely to be 
nonwhite (61.4% vs 
38.6%) and publicly 
insured (63.3%) versus 
privately insured (29.3%) 
or no insurance (7.58%). 
56% of participants 
provided urine samples 
and of those, 9.9% were 
positive for an STI. 
Controlling for other 
demographics, race was a 
significant predictor, 
which the odds of testing 
positive for nonwhite 
participants 5.90 times 





This was a 
convenience sample 
consisting largely of 
adolescent patients, 
who would require 
parental permission to 
enroll in the study. 
This requirement may 
bias the sample as 
adolescents who do not 
require parental 
permission may be 
more forthcoming with 
information and be 
more willing to 
participate. 
-Internal validity 
The questionnaire was 
not validated and 
survey data were 
obtained through 
patient report which 
may limit the 
interpretation of the 
results, as parents 
presence during 
completion of survey 
may have affected 
responses. 
Additionally, survey 
data were not linked to 
the STI testing results, 
which limited the 
ability to analyze 
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-External validity 
Due to the nature of 
the study, using a 
sample of students 
from one PED in an 
urban environment, 
there is limited 
generalizability to a 
larger population. 









Purpose: To increase 
chlamydia screening 
rates for young 
women receiving 
well-adolescent care 




the effect of the 
intervention on 
chlamydia test 
positivity rates and 
identifying the effect 
of the intervention 









visits during the 
study period of 
January 2016 to 
April 2018. 
Results: This practice-
based QI intervention to 
improve chlamydia 
screening in adolescent 
young women resulted in 
a statistically significant 
21% relative increase in 
routine chlamydia 
screening in a high 
chlamydia prevalence 
clinic. Additionally, there 
was no statistically 
significant difference in 
registration time or visit 





intervention site was a 
combined primary care 
and FP clinic with 
Title X funding, which 
allowed for 
confidential service 
delivery. Clinical sites 
without integrated 
sexual health services 
might face more 
extensive challenges to 
confidentiality 
management. 
-Auditability: The data 




were sexually active 
and instead used an 
ecologic approach 
using background rates 
of sexual activity in the 
local population. 
V A 
* From: Dang, D., & Dearholt, S. L. (2018). Johns Hopkins evidence-based practice: Model and 
guidelines (3rd ed.). Indianapolis, IN: Sigma Theta Tau.
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Note. Adapted from The Neuman Systems Model of Nursing [Overview of the Neuman Systems 
Model], by B. Neuman, 2005, https://www.neumansystemsmodel.org/neuman-fawcett-2011 
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Note. Age-based screening pathway for asymptomatic females, 24 years and younger. Adapted 
from Why Screen for Chlamydia? A How-to Implementation Guide for Healthcare Providers 
(3rd ed.), by the Altarum Institute, 2016, http://chlamydiacoalition.org/for-healthcare-
providers/why-screen-for-chlamydia/. Copyright 2006 by the Altarum Institute. 
 
  




Sexual History Screening Questionnaire 
 
1) Are you currently or have you ever been sexually active? 
2) Have you been tested for chlamydia in the past 12 months? 
3) Have you been tested for any STIs in the past 12 months? 
 
  









Figure I1. The lowdown on how to prevent STDs. Adapted from STD prevention infographics, 
by Centers for Disease Control and Prevention, 2020, 
https://www.cdc.gov/std/products/infographics.htm  
  





Figure I2. STIs among young Americans. Adapted from STD prevention infographics, Centers 
for Disease Control and Prevention, 2020, https://www.cdc.gov/std/products/infographics.htm 











































Check-in at front desk 
 
If negative SHSQ - 
Stop here 
 
If patient does not 
want CT/GC 
testing - Stop here 
 
Rooming and vital signs by the RN. 




If positive SHSQ – The RN will offer the 
patient CT/GC testing. 
 
 
If the patient would like CT/GC testing - 
they will be given a swab or urine cup 
for a self-collected 
Provider visit with discussion of sexual 
history, questions/concerns, testing, & 
treatment options. 
 
Provider lab order. 
 
RN packages specimen for lab. 
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 Monthly Total 
Practitioner $9,244 $36,976 
Registered Nurse $5,833 $23,332 
Project Manager $8,195 $32,780 
Total Salary Costs $93,088 *($0 for this project) 
Startup Costs  
 Monthly Total 
Education Handouts $5 $20 
EMR Consult $0 $175 
Total Startup Costs $195 
Total Project Expenses $93,283 *($195 for this project) 
Revenue Generated 
Revenue Generated $0 
Total Revenue Generated $0 
Program Benefit/Loss 
Total Revenue  $0 
Less Expenses  -$93,283  
*(-$195 for this project) 
Total Program Benefit/Loss  -$93,283  
*(-$195 for this project) 
*Note. For this project Total Salary Costs were $0, as MUHS staff were already in place and 
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---------- Forwarded message --------- 
From: IRB Administrator <noreply@axiommentor.com> 
Date: Wed, Jan 8, 2020 at 9:10 AM 
Subject: Full Board Approved - Revisions Complete - IRB ID: 2019-025 
To: <lh1234@messiah.edu> 
 
Messiah College IRB Approval Notification 
  
To:  Lacey Ehrenfeuchter 
From:  Michael Shin, IRB Chair 
Subject:  Protocol #2019-025 
Date:  01/08/2020 
  
The protocol #2019-025, Implementing Standardized Chlamydia Screening in a College 
Health Center has been approved by the Institutional Review Board on 12/04/2019. 
  
The approval of your study is valid through 12/03/2020, by which time you must submit an annual report either 
closing the protocol or requesting permission to continue the protocol for another year. Please submit your report 
by 11/05/2020 so that the IRB has time to review and approve your report if you wish to continue it for another year. 
  


















(N = 1613) 






Age     
Mean (SD) 20.16 (1.49) 20.29 (1.53) 20.55 (1.54) 20.25 (1.52) 
Ethnicity     
White 71% (n=1145) 68.1% (n=322) 46.2% (n=30) 71.6% (n=292) 
Black 11.5% (n=185) 16.5% (n=78) 27.7% (n=18) 14.7% (n=60) 
Hispanic 11.1% (n=179) 10.8% (n=51) 16.9% (n=11) 9.8% (n=40) 
Other 6.4% (n=104) 4.7% (n=22) 9.2% (n=6) 3.9% (n=16) 
Gender     
Male 33% (n=532) 26.4% (n=125) 40% (n=26) 24.3% (n=99) 
Female 67% (n=1081) 73.6% (n=348) 60% (n=39) 75.7% (n=309) 




Sexual Health Screening Questionnaire (SHSQ) Responses 
Spring 2020 
 
 Intervention (n=408) Total Visits (n=938) 
Sexually active   
Yes 92.6% (n=378) 43.7% (n=410) 
 
No 7.4% (n=30) 9.4% (n=88) 
Not assessed - 46.9% (n=440) 
Tested for CT past 12 months   
Yes 34.3% (n=140) 17.2% (n=161) 
 
No 65.2% (n=266) 28.5% (n=257) 
Not assessed 0.5% (n=2) 54.4% (n=510) 
Tested for STI past 12 months   
Yes 31.9% (n=130) 14% (n=131) 
 
No 58.3% (n=238) 25.5% (n=239) 
Not assessed 9.8% (n=40) 60.6% (n=568) 
 
  




Outcomes of Complaint Based CT Screening vs Standardized CT Screening 
 
 Pre-intervention (n=65) Post-intervention (n=408) 
Tested   
Yes 100% (n=65) 18.4% (n=75) 
No - 81.6% (n=333) 
Detected (CT Results)   
Positive 24.6% (n=16) 16% (n=12) 
Negative 75.4% (n=49) 84% (n=63) 
Treated*   
Yes 26 17 
No 39 58 
*All patients with positive results were treated, plus an additional 13.4% (n=15) of students who 
tested negative were also treated presumptively based on symptoms. 
 
 
